These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
662 related items for PubMed ID: 16449359
1. cGMP stimulates renin secretion in vivo by inhibiting phosphodiesterase-3. Beierwaltes WH. Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1376-81. PubMed ID: 16449359 [Abstract] [Full Text] [Related]
2. Nitric oxide synthase and cGMP-mediated stimulation of renin secretion. Sayago CM, Beierwaltes WH. Am J Physiol Regul Integr Comp Physiol; 2001 Oct; 281(4):R1146-51. PubMed ID: 11557622 [Abstract] [Full Text] [Related]
3. Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases. Manns JM, Brenna KJ, Colman RW, Sheth SB. Thromb Haemost; 2002 May; 87(5):873-9. PubMed ID: 12038792 [Abstract] [Full Text] [Related]
4. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents. Marcoz P, Prigent AF, Lagarde M, Nemoz G. Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905 [Abstract] [Full Text] [Related]
5. Potentiation of erectile response and cAMP accumulation by combination of prostaglandin E1 and rolipram, a selective inhibitor of the type 4 phosphodiesterase (PDE 4). Bivalacqua TJ, Champion HC, Rajasekaran M, Sikka SC, Kadowitz PJ, Doherty PC, Hellstrom WJ. J Urol; 1999 Nov; 162(5):1848-55. PubMed ID: 10524946 [Abstract] [Full Text] [Related]
6. The effect of Sildenafil on human platelet secretory function is controlled by a complex interplay between phosphodiesterases 2, 3 and 5. Dunkern TR, Hatzelmann A. Cell Signal; 2005 Mar; 17(3):331-9. PubMed ID: 15567064 [Abstract] [Full Text] [Related]
7. Inhibition of phosphodiesterase III with milrinone increases renin secretion in human subjects. Chiu YJ, Hu SH, Reid IA. J Pharmacol Exp Ther; 1999 Jul; 290(1):16-9. PubMed ID: 10381754 [Abstract] [Full Text] [Related]
9. Cyclic GMP and cyclic AMP induced changes in control and hypertrophic cardiac myocyte function interact through cyclic GMP affected cyclic-AMP phosphodiesterases. Weiss HR, Gong GX, Straznicka M, Yan L, Tse J, Scholz PM. Can J Physiol Pharmacol; 1999 Jun; 77(6):422-31. PubMed ID: 10537228 [Abstract] [Full Text] [Related]
11. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors. Rutten K, Prickaerts J, Hendrix M, van der Staay FJ, Sik A, Blokland A. Eur J Pharmacol; 2007 Mar 08; 558(1-3):107-12. PubMed ID: 17207788 [Abstract] [Full Text] [Related]
12. Role of cyclic GMP-inhibitable phosphodiesterase and nitric oxide in the beta adrenoceptor control of renin secretion. Chiu T, Reid IA. J Pharmacol Exp Ther; 1996 Aug 08; 278(2):793-9. PubMed ID: 8768733 [Abstract] [Full Text] [Related]
14. Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes. Picq M, Dubois M, Grynberg A, Lagarde M, Prigent AF. J Mol Cell Cardiol; 1996 Oct 08; 28(10):2151-61. PubMed ID: 8930810 [Abstract] [Full Text] [Related]
15. Modulation of relaxant responses evoked by a nitric oxide donor and by nonadrenergic, noncholinergic stimulation by isozyme-selective phosphodiesterase inhibitors in guinea pig trachea. Ellis JL, Conanan ND. J Pharmacol Exp Ther; 1995 Mar 08; 272(3):997-1004. PubMed ID: 7891355 [Abstract] [Full Text] [Related]
16. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle. Torphy TJ, Cieslinski LB. Mol Pharmacol; 1990 Feb 08; 37(2):206-14. PubMed ID: 2154670 [Abstract] [Full Text] [Related]
17. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes. Verde I, Vandecasteele G, Lezoualc'h F, Fischmeister R. Br J Pharmacol; 1999 May 08; 127(1):65-74. PubMed ID: 10369457 [Abstract] [Full Text] [Related]
18. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord. de Vente J, Markerink-van Ittersum M, Vles JS. J Chem Neuroanat; 2006 Jun 08; 31(4):275-303. PubMed ID: 16621445 [Abstract] [Full Text] [Related]
19. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis. Torphy TJ, Zhou HL, Burman M, Huang LB. Mol Pharmacol; 1991 Mar 08; 39(3):376-84. PubMed ID: 1848659 [Abstract] [Full Text] [Related]
20. "cAMP-specific" phosphodiesterase contributes to cGMP degradation in cerebellar cells exposed to nitric oxide. Bellamy TC, Garthwaite J. Mol Pharmacol; 2001 Jan 08; 59(1):54-61. PubMed ID: 11125024 [Abstract] [Full Text] [Related] Page: [Next] [New Search]